Patents by Inventor Uwe Pschorn

Uwe Pschorn has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20100330176
    Abstract: The invention relates to the use of ambroxol and the pharmacologically acceptable salts thereof for preparing a pharmaceutical composition for the treatment of painful conditions in the oral and pharyngeal cavity.
    Type: Application
    Filed: August 23, 2010
    Publication date: December 30, 2010
    Applicant: BOEHRINGER INGELHEIM PHARMA GMBH AND CO. KG
    Inventors: Anke ESPERESTER, Uwe PSCHORN, Jean-Michel VIX
  • Publication number: 20070224267
    Abstract: The invention relates to the use of ambroxol and the pharmacologically acceptable salts thereof for preparing a pharmaceutical composition for the treatment of painful conditions in the oral and pharyngeal cavity.
    Type: Application
    Filed: May 21, 2007
    Publication date: September 27, 2007
    Inventors: Uwe Pschorn, Jean-Michel Vix, Anke Esperester
  • Publication number: 20050256193
    Abstract: The invention relates to the use of ambroxol and the pharmacologically acceptable salts thereof for preparing a pharmaceutical composition for the treatment of painful conditions in the oral and pharyngeal cavity.
    Type: Application
    Filed: July 20, 2005
    Publication date: November 17, 2005
    Applicant: Boehringer Ingelheim Pharma GmbH & Co. KG
    Inventors: Anke Esperester, Uwe Pschorn, Jean-Michel Vix
  • Publication number: 20030166732
    Abstract: The invention relates to the use of ambroxol and the pharmacologically acceptable salts thereof for preparing a pharmaceutical composition for the treatment of painful conditions in the oral and pharyngeal cavity.
    Type: Application
    Filed: February 27, 2003
    Publication date: September 4, 2003
    Applicant: Boehringer Ingelheim Pharma GmbH & Co. KG
    Inventors: Anke Esperester, Uwe Pschorn, Jean-Michel Vix
  • Patent number: 6455538
    Abstract: Compounds of general formula I wherein X is a single bond, —O—, C-C4-alkylene, or an alkylene bridge having 1 to 8 carbon atoms which may be branched or unbranched and optionally have one or two oxygen atom(s) anywhere in the bridge; R1 is hydrogen, methyl, ethyl, or phenyl; R2 is hydrogen or methyl; R3 is hydrogen, fluorine, chlorine, bromine, hydroxy, methyl, or methoxy; R4 is hydrogen, methyl, or ethyl; R5 is hydrogen, methyl, or ethyl; R6 is hydrogen, methyl, or ethyl; R7 is tert-butyl, cyclohexyl, phenyl optionally substituted by R9 and R10, which may be identical or different, or; R8 is hydrogen or C1-C4-alkyl; Z is oxygen, NH, or sulfur; R9 is hydrogen, methyl, fluorine, chlorine, bromine, or methoxy; R10 is hydrogen, methyl, fluorine, chlorine, bromine, or methoxy; optionally in the form of the individual optical isomers, mixtures of the individual enantiomers or racemates as well as in the form of the free bases or the corresponding acid addition salts
    Type: Grant
    Filed: March 10, 2000
    Date of Patent: September 24, 2002
    Assignee: Boehringer Ingelheim Pharma KG
    Inventors: Matthias Grauert, Adrian Carter, Wolf-Dietrich Bechtel, Thomas Weiser, Rainer Palluk, Uwe Pschorn
  • Patent number: 6441237
    Abstract: The present patent application relates to new substituted 3-phenoxy- or 3-phenylalkyloxy-2-phenyl-propylamines of general formula 1, processes for preparing them and their use as pharmaceutical compositions.
    Type: Grant
    Filed: February 18, 2000
    Date of Patent: August 27, 2002
    Assignee: Boehringer Ingelheim Pharma KG
    Inventors: Werner Stransky, Matthias Grauert, Adrian Carter, Thomas Weiser, Wolf-Dietrich Bechtel, Helmut Ensinger, Ralf Richard H. Lotz, Rainer Palluk, Uwe Pschorn
  • Patent number: 6277872
    Abstract: The invention relates to oxadiazole derivatives of general formula (I) wherein X, Y, Z and R1 are defined as described in the specification and claims, processes for preparing them and their use as pharmaceutical compositions.
    Type: Grant
    Filed: July 26, 1999
    Date of Patent: August 21, 2001
    Assignee: Boehringer Ingelheim KG
    Inventors: Michael Brenner, Roland Maier, Marion Wienrich, Thomas Weiser, Rainer Palluk, Wolf-Dietrich Bechtel, Angelo Sagrada, Helmut Ensinger, Uwe Pschorn, Raffaele Cesana
  • Patent number: 6051583
    Abstract: The present invention relates to new substituted 2,3,3a,4,9,9a-hexahydro-8-hydroxy-1H-benz[f]indole derivatives, processes for preparing them and their use as pharmaceutical compositions.
    Type: Grant
    Filed: July 30, 1999
    Date of Patent: April 18, 2000
    Assignee: Boehringer Ingelheim Pharma KG
    Inventors: Matthias Grauert, Christoph Hoenke, Adrian Carter, Wolf-Dietrich Bechtel, Thomas Weiser, Rainer Palluk, Uwe Pschorn